# Compassionate Use of Stanate (TM) [Stannsoporfin]

> **NCT00076960** · — · NO_LONGER_AVAILABLE · sponsor: **InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company**

## Conditions studied

- Neonatal Jaundice
- Hyperbilirubinemia

## Interventions

- **DRUG:** Stanate (TM) [stannsoporfin, tin-mesoporphyrin]

## Key facts

- **NCT ID:** NCT00076960
- **Lead sponsor:** InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076960, "Compassionate Use of Stanate (TM) [Stannsoporfin]". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00076960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*